Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Farmakogenetika i Farmakogenomika
Farmakogenetika i Farmakogenomika is Scopus-indexed, DOAJ. Published by Publishing House OKI.
Checked against the index lists dated .
ISSN 2588-0527Verify ISSN ↗2686-8849Verify ISSN ↗
Publisher: Publishing House OKI
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Farmakogenetika i Farmakogenomika indexed in Scopus?
Listed in Scopus, coverage 2025–present, but Scopus has not published a current CiteScore for this title — it may be newly indexed and not yet evaluated. Confirm its active status directly with Scopus before submitting.
What is the impact factor of Farmakogenetika i Farmakogenomika?
Farmakogenetika i Farmakogenomika has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Farmakogenetika i Farmakogenomika and what is its ISSN?
Farmakogenetika i Farmakogenomika is published by Publishing House OKI. Its print ISSN is 2588-0527 and its online ISSN is 2686-8849.
Is Farmakogenetika i Farmakogenomika in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Farmakogenetika i Farmakogenomika open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Farmakogenetika i Farmakogenomika? — open metrics via OpenAlex
Farmakogenetika i Farmakogenomika has an h-index of 4 and a 2-year mean of 0.5 citations per paper (OpenAlex).
Farmakogenetika i Farmakogenomika published 24 papers in 2025; its busiest recent year was 2023 with 32. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Farmakogenetika i Farmakogenomika? — latest 95 articles, 2021–2026
In its latest 95 research articles (2021–2026), authors are most often from Russia (95.8%), Belarus (1.1%) and Kazakhstan (1.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Farmakogenetika i Farmakogenomika? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration95.8% of recent authorship from Russia
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
1 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.